You are here

Article Text

Article menu

Download PDFPDF

Therapeutics
Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care.
Free

https://doi.org/10.1136/ebm.12.6.172

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In elderly patients with atrial fibrillation (AF) in primary care, is warfarin more effective than aspirin for preventing major stroke, arterial embolism, and intracranial haemorrhage?

    Mant J, Hobbs FDR, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493–503.

    Clinical impact ratings GP/FP/Primary care ★★★★★★⋆ Geriatrics ★★★★★★⋆ Cardiology ★★★★★★⋆ Haematology ★★★★★★⋆ Neurology ★★★★★★⋆

    METHODS

    Embedded ImageDesign:

    randomised controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged [BAFTA] study).

    Embedded ImageAllocation:

    concealed.*

    Embedded ImageBlinding:

    blinded (outcome assessors).*

    Embedded ImageFollow-up period:

    mean 2.7 years.

    Embedded ImageSetting:

    234 general practices in England and Wales.

    Embedded ImagePatients:

    973 patients ⩾75 years of age (mean age 81y, 55% men) with AF or flutter within the past 2 years (confirmed by electrocardiography). Exclusion criteria included terminal illness, rheumatic heart disease, major …

    View Full Text